Ownership of Eli Lilly and Company (ticker LLY) is heavily concentrated among massive global institutional asset management firms, index fund providers, and specialized healthcare funds. Major institutional stakeholders holding significant blocks of common stock include global investment powerhouses such as The Vanguard Group, BlackRock, State Street Global Advisors, and various long-term philanthropic foundations and insider stakeholders.